Table 1

Schedule for data collection and visits 

NormalBaselineAllocationTreatmentFollow-up
Prior to enrolmentPrior to surgerySurgeryStandard non-study postoperative visit6 weeks (by post)Visit 1: 3 months6 months (by post)Visit 2: 12 months
Medical and ocular history
Consent for cataract surgery
Informed consent and eligibility screening
Identification of study eye
Visual acuity: UDVA, pinhole, +/− glasses (Snellen)✓*
Visual acuity (logMAR) with usual method of correction
Visual acuity: UDVA† and CDVA‡ (logMAR) each eye and binocular
Subjective refraction
Ocular biometry
Pentacam corneal topography✓§
Optical coherence tomography (OCT)✓§✓§
Inclusion/exclusion criteria
Catquest-9SF questionnaire
EQ-5D-3L+vision bolt-on question (EQ-5DV)
CSRI**
Endothelial cell count measurement✓§
Randomisation
Treatment: standard care: Manual Phacoemulsification Cataract Surgery
Treatment: Intervention: Femtosecond Laser-Assisted Phacoemulsification Cataract Surgery
Adverse event collection✓††✓††
  • *Current glasses or unaided.

  • †UDVA: uncorrected distance visual acuity. All visual acuity measures will use the standard ETDRS logMAR chart at 4 metres.

  • ‡CDVA: corrected distance visual acuity using subjective refraction result.

  • §Some patients will have these tests performed at the standard preassessment visit, depending on the site local procedure for surgical preassessment.

  • **The CSRI is a questionnaire for collecting retrospective information about study patients’ use of health and social care services, accommodation and living situation, income, employment and benefits.17

  • ††Patient reported complications only.

  • CDVA, corrected distance visual acuity; CSRI, Client Service Receipt Inventory; ETDRS, Early Treatment Diabetic Retinopathy Study; UDVA, uncorrected distance visual acuity.